The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessing the value of repeat next generation testing in patients with non-small cell lung cancer: A retrospective review.
 
Brian Warnecke
No Relationships to Disclose
 
Angelo Cabal
No Relationships to Disclose
 
Zhaohui Arter
No Relationships to Disclose
 
Hari B. Keshava
Honoraria - AstraZeneca; Intuitive Surgical
Consulting or Advisory Role - AstraZeneca; Noah Medical
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Intuitive Surgical
 
Jeremy Phillip Harris
Leadership - DSMB University of California Irvine
Consulting or Advisory Role - Novocure
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - BloosomHill therapeutics; Elevation Oncology; Lilly; MBrace Therapeutics; Nuvalent, Inc.; Turning Point Therapeutics
Honoraria - BMS; Daiichi Sankyo; Dava Oncology; Johnson & Johnson/Janssen; Pfizer; Pfizer
Consulting or Advisory Role - AnHeart Therapeutics; Daiichi Sankyo; Janssen; Pfizer; Takeda
Research Funding - ARIAD (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); BMS (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Nuvalent, Inc. (Inst); Pfizer (Inst); Revolution Medicines (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
Misako Nagasaka
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Daiichi Sankyo; EMD Serono; Genentech; Janssen; Lilly; Mirati Therapeutics; Novartis; Pfizer; Takeda
Speakers' Bureau - Blueprint Medicines; Janssen; Mirati Therapeutics; Mirati Therapeutics; Takeda
Research Funding - Tempus
Travel, Accommodations, Expenses - Anheart Therapeutics